Drugs & Targets FDA grants priority review to MCNA in certain bladder cancer patients October 30, 2015Vol.41 No.40
Drugs & Targets Imlygic Approved as First U.S. Oncolytic Viral Cancer Therapy October 30, 2015Vol.41 No.40
Drugs & TargetsFree FDA grants de novo clearance to Sonablate 450 for prostate tissue October 23, 2015Vol.41 No.39
Drugs & TargetsFree Yondelis approved for liposarcoma and leiomyosarcoma October 23, 2015Vol.41 No.39
Drugs & TargetsFree Onivyde Regimen Approved for Metastatic Pancreatic Cancer October 23, 2015Vol.41 No.39
Drugs & Targets Sequenom to collaborate with University Medical Center Hamburg-Eppendorf October 16, 2015Vol.41 No.38
Drugs & Targets Eli Lilly and Innovent expand their anti-PD-1 collaboration October 16, 2015Vol.41 No.38
